Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid

Senescence Wrinkles, Acne, Pitting Scar Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

The overall goal of this study is to evaluate the safety and exploratory efficacy of the injectable filler agent composed of umbilical cord mesenchymal stem cells and hyaluronic acid for the improvement of wrinkles, acne, pitting scar and so on.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Senescence Wrinkles, Acne, Pitting Scar

• NCT number: NCT02698813
• Study type: Interventional
• Source: South China Research Center for Stem Cell and Regenerative Medicine
• Contact: Xuetao Pei, M.D., Ph.D
• Phone: 8610-68164807
• Email: AMMS0906@163.com
• Status: Not yet recruiting
• Phase: Phase 1
• Start date: December 2016